THE DEAL, AT A GLANCE
From the announcementAlto Pharmacy
01What it doesThe new capital is framed around Expand to 10 new cities and build Alto AI medication adherence platform.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Jackson SquareFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAlto Pharmacy raised $200M Series EFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersAlto Pharmacy’s Series E supports expansion of an AI-powered pharmacy delivery model with clinical support into additional markets.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Alto Pharmacy · Financing Record
Explore source-linked visual explanations for Alto Pharmacy. Unsupported claims are withheld while source review continues.
Record 1528 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →